BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma
byPerelman School of Medicine at the University of PennsylvaniaMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0An experim
Updated on: December 22,2023
BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma
byPerelman School of Medicine at the University of PennsylvaniaMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0An experim
Updated on:December 22,2023
